thumbnail image
broken image
broken image
broken image
  • Home
  • Clinicians
  • Our story
  • Team
  • Methodology
  • Contact
  • …  
    • Home
    • Clinicians
    • Our story
    • Team
    • Methodology
    • Contact
Join Free WhatsApp Group
broken image
broken image
broken image
  • Home
  • Clinicians
  • Our story
  • Team
  • Methodology
  • Contact
  • …  
    • Home
    • Clinicians
    • Our story
    • Team
    • Methodology
    • Contact
Join Free WhatsApp Group
broken image
  • It all starts with an idea...

    Dr Oliver Zolman MBBS BSc is a leading longevity doctor and scientist specialising in evidence-based health optimisation and rejuvenation medicine. A graduate of King’s College London, he holds a First Class Honours degree in Regenerative Medicine and completed a Visiting Fellowship in Evidence-Based Medicine at the University of Sydney.

     

    Oliver is at the forefront of ageing research, aiming to reverse biological aging across all 81 organ types and achieve longevity escape velocity (LEV) by 2030. As the founder of 20one Consulting and a creator of Project Blueprint with entrepreneur Bryan Johnson, Dr Zolman applies cutting-edge science to create personalised, results-driven health and longevity strategies.

     

    His work has been featured in the BBC, Bloomberg, The Times, Guardian, New York Post, Piers Morgan, GQ, Rolling Stone, The Onion, and the 2025 Netflix Documentary "Don't Die".

  • Tests, Therapies & Services Conflicts of Interest Statement

    Why is this important? There is a potential for people to exaggerate or unfairly focus on the benefits or risks of tests, therapies or services when they can profit professionally or financially from this information. It is Good Business Practice to declare conflicts of interest.

     

    Where there is a conflict of interest, these people have no involvement in the research, inclusion or design of conflicted content in Longevity.School. Longevity.School's conflict of interest policy maintains the fully independent nature of our content.

    Bill Cherman

    Holds equity in various pre-commercial rejuvenation biotechnology companies, including Dante Labs

    Dr Oliver Zolman MBBS BSc

    Holds equity in Dante Labs consumer whole genome sequencing company

    Dr Aubrey de Grey, PhD

    CSO at LEV Foundation

    Dr Patrick Sewell, MD

    Founder at www.triplhelix.com

    Dr Avi Roy, DPhil

    Founder at Zolman Clinics, UDA

  • Join the whatsapp group

    CHOOSE GROUP
broken image

Our Brands

OliverZolman.com

TriplHelix

Previous Projects

RejuvenationOlympics

Blueprint

Join Free WhatsApp Group

Terms & Conditions

Channels

YouTube

Instagram

LinkedIn

Copyright 2016-2025 20one Consulting Ltd.

UK Registration: 10299987 ICO Registration: ZA297182

 

Legal

Products and Services do not provide medical advice and are for educational or clinical training purposes only. For non-clinicians, do not make any changes to your behaviours without consulting your licensed clinicians first. See the medical disclaimer within the terms and conditions.

    Checkout
Cookie Use
We use cookies to ensure a smooth browsing experience. By continuing we assume you accept the use of cookies.
Learn More